Carvedilol Tablet, Film Coated
Product Images NDC 51655-030

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 51655-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 030 25 Master Bottle Label Approval Rev A 04 22)

Label for Carvedilol tablets, USP, 12.5 mg strength, film-coated, oral dosage form. The package contains 60 tablets for prescription use only. Labeler is Northwind Health Company, LLC. Storage instructions advise keeping the container at 20°-25°C (68°-77°F) and protecting from moisture and children. The label includes lot, expiration, and packaging information.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure of carvedilol showing its molecular arrangement with functional groups including methoxyphenyl and indole components.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A line graph showing percentage mortality over 21 months comparing Carvedilol and placebo groups. The graph depicts mortality increasing over time, with the Carvedilol group showing a consistently lower percentage mortality than the placebo group, indicating a difference in survival outcomes.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot chart depicting hazard ratios with confidence intervals across various patient subgroups, including gender, age, race, diabetic status, ischemic condition, heart rate, systolic blood pressure, and spironolactone use, concluding with an overall patient group. The x-axis represents the hazard ratio scale.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph comparing the percentage mortality over 24 months between Carvedilol and placebo groups. The x-axis represents months, while the y-axis indicates percentage mortality. The plot shows a lower mortality rate for Carvedilol compared to placebo, with a significance value (P = 0.03) noted on the graph.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot chart displaying hazard ratios for various patient subgroups, including age, gender, prior myocardial infarction timing, prior use of Warfarin or beta-blockers, Killip class, thrombolytic therapy status, percutaneous transluminal coronary angioplasty (PTCA) for myocardial infarction, congestive heart failure presence, diuretics use, angina status, hypertension status, diabetes status, heart rate, systolic blood pressure, and all patients. Each subgroup is represented with a point estimate and confidence interval on a horizontal axis ranging approximately from 0.4 to 1.3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.